David J. Wambeke, Chief Business Officer of NeuroOne Medical Technologies Corp ($NMTC), made one open market purchase of common shares in the last 365 days, totaling $670 thousand. His most recent buy occurred on March 1, 2026. This ranks 693rd among 4,983 insiders by purchase value, below the average of $1.46 million across 3.29 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2026 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Wambeke David J. | Chief Business Officer | P | Common Stock | 1000000 | $0.67 | 1,000,000.0000 | 50,331,155 | 9999.99% | 1.99% |
| March 1, 2026 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Wambeke David J. | Chief Business Officer | A | Option to Purchase Common Stock | 500000 | $0.00 | 500,000.0000 | 50,331,155 | 9999.99% | 0.99% |
| June 1, 2025 | DiaMedica Therapeutics Inc. | $DMAC | Wambeke David J. | Chief Business Officer | A | Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 42,855,660 | 9999.99% | 0.58% |
| June 1, 2024 | DiaMedica Therapeutics Inc. | $DMAC | Wambeke David J. | Chief Business Officer | A | Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 16, 2023 | DiaMedica Therapeutics Inc. | $DMAC | Wambeke David J. | Chief Business Officer | P | Voting Common Shares, no par value per share | 20000 | $2.46 | 527,114.0000 | 0 | 3.94% | 0.00% |
| June 23, 2023 | DiaMedica Therapeutics Inc. | $DMAC | Wambeke David J. | Chief Business Officer | P | Voting Common Shares, no par value per share | 38364 | $3.91 | 507,114.0000 | 0 | 8.18% | 0.00% |
| April 10, 2023 | DiaMedica Therapeutics Inc. | $DMAC | Wambeke David J. | Chief Business Officer | P | Voting Common Shares, no par value per share | 468750 | $1.60 | 468,750.0000 | 0 | 9999.99% | 0.00% |
| April 10, 2023 | DiaMedica Therapeutics Inc. | $DMAC | Wambeke David J. | Chief Business Officer | A | Stock Option (right to buy) | 140000 | $0.00 | 140,000.0000 | 0 | 9999.99% | 0.00% |